Prevalence of C3 mutations in primary membranoproliferative glomerulonephritis

Elisabetta Valoti; Elena Bresin; Rossella Piras; Marta Alberti; Annalisa Sorosina; Roberta Donadelli; Giuseppe Remuzzi; Marina Noris

doi:10.1016/j.molimm.2013.05.050

Related publications

Article2018

Autoimmune abnormalities of the alternative complement pathway in membranoproliferative glomerulonephritis and C3 glomerulopathy

Marina Noris, Roberta Donadelli, Giuseppe Remuzzi

Article2021

CFH and CFHR Copy Number Variations in C3 Glomerulopathy and Immune Complex-Mediated Membranoproliferative Glomerulonephritis

Rossella Piras, Matteo Breno, Elisabetta Valoti, Marta Alberti, Paraskevas Iatropoulos, Caterina Mele, Elena Bresin, Roberta Donadelli, Paola Cuccarolo, Richard J. Smith, Ariela Benigni, Giuseppe Remuzzi, Marina Noris

Article2024

#1467 Pegcetacoplan for post-transplant recurrent C3 glomerulopathy or immune complex membranoproliferative glomerulonephritis in NOBLE: 12-week evolution

Fádi Fakhouri, Andrew S. Bomback, David Kavanagh, Giuseppe Remuzzi, Gere Sunder‐Plassmann, John Kanellis, Erica Daina, Patrick D. Walker, Zhongshen Wang, Zurish Ahmad

Article2015

Glomerular Diseases Dependent on Complement Activation, Including Atypical Hemolytic Uremic Syndrome, Membranoproliferative Glomerulonephritis, and C3 Glomerulopathy: Core Curriculum 2015

Marina Noris, Giuseppe Remuzzi

Article2024

Pegcetacoplan for Post-transplant Recurrent C3 Glomerulopathy (C3G) or Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN) in NOBLE: 52-Week Patient Evolution

Anuja Java, Andrew S. Bomback, David Kavanagh, Giuseppe Remuzzi, Gere Sunder‐Plassmann, John Kanellis, Erica Daina, Patrick D. Walker, Zhongshen Wang, Zurish Ahmad, Fádi Fakhouri